About 30 million Americans use GLP-1 drugs, which chemically suppress appetite and reduce fast food demand by 27-30%. This structural shift benefits companies like Amazon, which is expanding its pharmacy and delivery services; Eli Lilly, leading with injectable and new oral GLP-1 drugs; Novo Nordisk, a pioneer with new oral options despite stock declines; Sprouts Farmers Market, catering to healthier eating trends; and Hims & Hers Health, transitioning to branded GLP-1 distribution. Investors should watch these stocks as the fast food industry faces a major market contraction over the next few earnings cycles.
Shares of Arm surged 11% and Qualcomm rose 5% following strong earnings and growth prospects in the chip-architecture sector. Arm reported a 20% revenue increase, driven by booming demand for its AI-focused data center chips, with over $2 billion in ...
SpaceX's IPO, the largest ever, has drawn significant investor attention with a $1.78 trillion valuation and $47.8 billion in revenue from multiple fast-growing segments including Starlink broadband, launch services, and AI compute infrastructure. Op...
In 2026, five major tech companies—Alphabet, Amazon, Meta, Microsoft, and Oracle—have issued $159 billion in bonds, surpassing their total debt from 2020-2024. This surge funds massive investments in AI infrastructure like data centers and advanced p...
InterDigital's stock surged 11.3% following a new patent license agreement with Amazon covering streaming technology for services like Amazon Prime Video. This deal resolves ongoing litigation and marks a strategic expansion for InterDigital into vid...
Global investment in artificial intelligence has surged to $700 billion, driven by strong private sector funding and coordinated government initiatives worldwide. The U.S. led with $109.1 billion in private AI investments in 2024, while the EU and co...
